Advisor Group, Inc. - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$4,000
-94.9%
34,514
-26.1%
0.00%
-100.0%
Q3 2018$79,000
-8.1%
46,714
-4.8%
0.00%0.0%
Q2 2018$86,000
-36.8%
49,064
-33.5%
0.00%
-50.0%
Q1 2018$136,000
+41.7%
73,814
+71.2%
0.00%
+100.0%
Q4 2017$96,000
-24.4%
43,114
-1.2%
0.00%
-50.0%
Q3 2017$127,000
+11.4%
43,650
+70.3%
0.00%0.0%
Q2 2017$114,000
+18.8%
25,625
+25.2%
0.00%0.0%
Q1 2017$96,000
+50.0%
20,475
+94.1%
0.00%
+100.0%
Q4 2016$64,000
+33.3%
10,550
+20.6%
0.00%0.0%
Q3 2016$48,000
+1500.0%
8,750
+775.0%
0.00%
Q2 2016$3,0001,0000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2018
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders